Alerts will be sent to your verified email
Verify EmailVENMAX
|
Venmax Drugs&Pharma
|
Ishita Drugs & Inds.
|
Desh Rakshak Aushdh
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-46.46 % | 8.38 % | 4.74 % |
|
5yr average Equity Multiplier
|
0.08 | 1.27 | 1.73 |
|
5yr Average Asset Turnover Ratio
|
0.14 | 1.23 | 0.39 |
|
5yr Avg Net Profit Margin
|
-19.62 % | 5.43 % | 7.09 % |
|
Price to Book
|
2.45 | 1.87 | 1.4 |
|
P/E
|
60.68 | 21.59 | 27.71 |
|
5yr Avg Cash Conversion Cycle
|
288.55 Days | 74.52 Days | -280.35 Days |
|
Inventory Days
|
5.2 Days | 35.08 Days | 36.63 Days |
|
Days Receivable
|
430.69 Days | 31.6 Days | 363.29 Days |
|
Days Payable
|
141.12 Days | 42.7 Days | 408.55 Days |
|
5yr Average Interest Coverage Ratio
|
-260.56 | 24.46 | 2.89 |
|
5yr Avg ROCE
|
-47.43 % | 11.48 % | 6.6 % |
|
5yr Avg Operating Profit Margin
|
-65.91 % | 6.66 % | 19.52 % |
|
5 yr average Debt to Equity
|
-0.45 | 0.09 | 0.38 |
|
5yr CAGR Net Profit
|
-42.57 % | 0.95 % | 2.71 % |
|
5yr Average Return on Assets
|
199.45 % | 6.68 % | 2.74 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
15.14 % | 50.04 % | 50.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-7.99 % | 0.72 % | -14.25 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venmax Drugs&Pharma
|
Ishita Drugs & Inds.
|
Desh Rakshak Aushdh
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|